Centre hospitalier de Roubaix

The trials here

What the 19 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia6 trials
• Crohn's disease3 trials
• Acute lymphoblastic leukaemia2 trials
• Myeloproliferative neoplasms2 trials
• Asthma1 trial
• Chronic kidney disease1 trial
• Gastric and oesophageal cancer1 trial
• High blood pressure1 trial
• Multiple myeloma1 trial
• Psoriasis1 trial
• Stroke1 trial

Phase

• Phase 36 trials
• Phase 44 trials
• Phase 23 trials
• Phase 2/32 trials

Status

• Recruiting10 trials
• Completed4 trials
• Not yet recruiting3 trials
• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Acute Leukemia French Association2 trials
• Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives2 trials
• University Hospital, Lille2 trials
• Assistance Publique - Hôpitaux de Paris1 trial
• Assistance Publique Hopitaux De Paris1 trial
• and 11 more

Running trials

• Not yet recruiting

  Tenecteplase for the treatment of acute stroke in the late time window before inter-hospital transfer for thrombectomy: a randomized controlled trial

  2026-525280-40-00· Phase 3· Fondation A De Rothschild· Source

• Not yet recruiting

  Prospective evaluation of response to treatment by analysis of measurable residual disease in younger adult patients (18-60 years) with acute myeloid leukemia (AML). The Backbone InterGroup (BIG)-2 umbrella trial from the Acute Leukemia French Intergroup (ALFA, FILO) - BIG2

  2026-525759-96-00· Phase 4· Centre Hospitalier Universitaire De Toulouse· Source

• Recruiting

  Optimal Care With Guselkumab in Crohn's Disease / OPTIM Study A Prospective Open Label Interventional, Multicenter Study

  NCT07616687· Phase 4· Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives· Source

• Not yet recruiting

  A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APPROACH. ALL-TARGET TRIAL

  2024-516570-30-00· Phase 2· Centre Hospitalier De Versailles· Source

• Recruiting

  Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  NCT07007312· Phase 3· Kura Oncology, Inc.· Source

• Recruiting

  A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)

  NCT06701513· Bristol-Myers Squibb· Source

  Contact: OLIVIER CARPENTIER, Site 046

• Recruiting

  Comparison of azathioprine to methotrexate in combination therapy with adalimumab in Crohn’s Disease: an open-label randomized controlled trial

  2024-514633-38-00· Phase 3· Centre Hospitalier Universitaire Amiens Picardie· Source

• Recruiting

  Apixaban/rivaroxaban Versus Aspirin for primary prevention of thrombo-embolic complications in JAK2V617F-positive myeloproliferative neoplasms

  2024-515362-13-00· Phase 2/3· Centre Hospitalier Regional Et Universitaire De Brest· Source

• Recruiting

  CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics

  NCT05260528· Phase 2· Centre Hospitalier Universitaire de Nice· Source

• Recruiting

  Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease

  NCT05732727· Phase 3· University Hospital, Tours· Source

• Recruiting

  Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)

  NCT04777916· Acute Leukemia French Association· Source

  Contact: Isabelle PLANTIER, MD

• Recruiting

  Short Treatment with Omalizumab for Severe Asthma

  NCT04763447· Phase 4· Assistance Publique - Hôpitaux de Paris· Source

• Completed

  USTekinumab in Fistulising Perianal Crohn's Disease (USTAP)

  NCT04496063· Phase 4· Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives· Source

• Recruiting

  GRAALL2014

  NCT02617004· Phase 2· Assistance Publique Hopitaux De Paris· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia4 recruiting
• Acute lymphoblastic leukaemia2 recruiting
• Crohn's disease2 recruiting
• Asthma1 recruiting
• Chronic kidney disease1 recruiting
• High blood pressure1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Psoriasis1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  Multicenter Retrospective Observatory of Patients With Acute Myeloid Leukemia to Core Binding Factor

  NCT05070208· Acute Leukemia French Association· Source

• Terminated

  To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

  NCT04551066· Phase 3· Incyte Corporation· Source

• Completed

  Compare Lenalidomide and Subcutaneous Daratumumab vs Lenalidomide and Dexamethasone in Frail Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose Therapy

  NCT03993912· Phase 3· University Hospital, Lille· Source

• Completed

  Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers

  NCT03246516· University Hospital, Lille· Source

• Recruiting

  Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

  NCT02416388· Phase 2/3· University Hospital, Angers· Source